WO2023234899 - A BILAYER TABLET FORMULATION COMPRISING EMPAGLIFLOZIN AND METFORMIN

National phase entry:
Publication Number WO/2023/234899
Publication Date 07.12.2023
International Application No. PCT/TR2023/050469
International Filing Date 25.05.2023
Title [English] A BILAYER TABLET FORMULATION COMPRISING EMPAGLIFLOZIN AND METFORMIN [French] FORMULATION DE COMPRIMÉ BICOUCHE COMPRENANT DE L'EMPAGLIFLOZINE ET DE LA METFORMINE
Applicants ** SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI Esentepe Mahallesi Bahar Sokak Ozdilek River Plaza Vyndham Grand No:13 Ic Kapi No:10 Sisli/Istanbul, TR
Inventors ** SUNEL, Fatih Istınye Mahallesı Balabandere Caddesı No:14 34460 Sarıyer/Istanbul, TR PEHLIVAN AKALIN, Nur Istınye Mahallesı Balabandere Caddesı No:14 34460 Sarıyer/Istanbul, TR ARMUT, Merve Istınye Mahallesı Balabandere Caddesı No:14 34460 Sarıyer/Istanbul, TR GULER, Tolga Istınye Mahallesı Balabandere Caddesı No:14 34460 Sarıyer/Istanbul, TR
Priority Data 2022/008870  31.05.2022  TR
Application details
International Searching Authority
Translation

Recalculate

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country Stages Total
China Filing 1019
EPO Filing, Examination 4751
Japan Filing 577
South Korea Filing 576
USA Filing, Examination 2635
MasterCard Visa
Total: 9558
The term for entry into the National Phase has expired. This quotation is for informational purposes only.

Abstract [English] The present invention relates to a bilayer tablet comprising empagliflozin and metformin, the tablet provides the desired stability and pharmacotechnical properties and the desired dissolution profile. The present invention also relates to a simple, rapid, cost effective, time-saving and industrially convenient method of preparing the bilayer tablet. [French] La présente invention concerne un comprimé bicouche comprenant de l'empagliflozine et de la metformine, le comprimé assurant la stabilité et les propriétés pharmacotechniques souhaitées et le profil de dissolution souhaité. La présente invention concerne également un procédé simple, rapide, économique, économe en temps et industriellement pratique de préparation du comprimé bicouche.